Suppr超能文献

维生素D代谢产物对实验性肾衰竭中骨化三醇代谢的影响。

Effect of vitamin D metabolites on calcitriol metabolism in experimental renal failure.

作者信息

Patel S, Simpson R U, Hsu C H

机构信息

Department of Internal Medicine and Pharmacology, University of Michigan Medical School, Ann Arbor.

出版信息

Kidney Int. 1989 Aug;36(2):234-9. doi: 10.1038/ki.1989.185.

Abstract

Previous studies from our laboratory have demonstrated that metabolic clearance rate (MCR) of calcitriol is decreased in experimental renal failure. In this experiment, we examined the effects of calcitriol, 25-hydroxyvitamin D3 (25(OH)D3) and 24,25-dihydroxyvitamin D3 (24,25(OH)2D3) on the MCR of calcitriol in renal failure produced in rats by partial nephrectomy. The MCR of calcitriol in these rats with renal failure was significantly lower than in control rats with sham operations. Plasma concentrations of calcitriol did not differ between the rats with moderate renal failure and control rats (sham, 74.7 +/- 3.6 pg/ml, N = 7; renal failure, 67.7 +/- 6.0, N = 6; serum creatinine 0.56 +/- 0.02 mg/dl vs. 0.96 +/- 0.02); however, the levels were significantly lower in rats with severe renal failure (sham, 66.5 +/- 5.1 pg/ml, N = 7, severe renal failure, 49.6 +/- 2.1 pg/ml, N = 8; serum creatinine 0.53 +/- 0.01 mg/dl vs. 1.40 +/- 0.03). Subcutaneous infusion of calcitriol (10 ng/kg/day) in rats with severe renal failure for one week significantly increased the MCR of calcitriol (0.22 +/- .01 vs. 0.17 +/- .01 ml/min/kg, P less than 0.001). Infusion of 25(OH)D3 (600 ng/day) or 24,25(OH)2D3 (1 microgram/day) in rats with renal failure for one week also increased the MCR of calcitriol (25(OH)D3, 0.25 +/- 0.01 ml/min/kg; 24,25(OH)2D3, 0.25 +/- 0.01, both P less than 0.001) when compared to rats with renal failure infused with vehicle (0.21 +/- 0.01). Administration of 24,25(OH)2D3 significantly lowered the plasma levels of calcitriol in rats with renal failure (52.3 +/- 3.1 pg/ml, P less than 0.05) in comparison to the rats with renal failure infused with vehicle (67.7 +/- 6.0).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

我们实验室之前的研究表明,实验性肾衰竭时骨化三醇的代谢清除率(MCR)降低。在本实验中,我们研究了骨化三醇、25-羟基维生素D3(25(OH)D3)和24,25-二羟基维生素D3(24,25(OH)2D3)对部分肾切除所致大鼠肾衰竭中骨化三醇MCR的影响。这些肾衰竭大鼠的骨化三醇MCR显著低于假手术对照组大鼠。中度肾衰竭大鼠与对照组大鼠(假手术组,74.7±3.6 pg/ml,N = 7;肾衰竭组,67.7±6.0,N = 6;血清肌酐0.56±0.02 mg/dl对0.96±0.02)的骨化三醇血浆浓度无差异;然而,重度肾衰竭大鼠的水平显著较低(假手术组,66.5±5.1 pg/ml,N = 7,重度肾衰竭组,49.6±2.1 pg/ml,N = 8;血清肌酐0.53±0.01 mg/dl对1.40±0.03)。对重度肾衰竭大鼠皮下输注骨化三醇(10 ng/kg/天)一周可显著提高骨化三醇的MCR(0.22±.01对0.17±.01 ml/min/kg,P<0.001)。对肾衰竭大鼠输注25(OH)D3(600 ng/天)或24,25(OH)2D3(1μg/天)一周也可提高骨化三醇的MCR(25(OH)D3为0.25±0.01 ml/min/kg;24,25(OH)2D3为0.25±0.01,P均<0.001),与输注赋形剂的肾衰竭大鼠(0.21±0.01)相比。与输注赋形剂的肾衰竭大鼠(67.7±6.0)相比,给予24,25(OH)2D3可显著降低肾衰竭大鼠的骨化三醇血浆水平(52.3±3.1 pg/ml,P<0.05)。(摘要截短至250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验